Clin2
NCT07270796Possibly a fitNot yet recruiting

DuoChol oral cholera vaccine safety study

Cholera Vaccination Reaction

Part of Infections clinical trials.

This study tests a new oral cholera vaccine called DuoChol to see if it is safe and helps your body build protection. It might be an option for healthy adults who want to help develop a better vaccine against cholera.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old.
  • You need a Swedish (or other nationality) ID card.
  • You must be generally healthy, with no serious medical conditions.
  • You cannot take heartburn or stomach-acid medication for 7 days before and 1 day after each vaccine dose.
  • If female, you must not be pregnant or breastfeeding, and must use birth control for the study period.
  • You must not have received a cholera vaccine before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07107516Recruiting· Phase 1
Testing an oral cholera vaccine in healthy adults

This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.

Lusaka, Lusaka Province
NCT07509047Recruiting· Phase 2
Cholera vaccine safety study for adults and children

This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.

Nairobi, Kenyatta National Hospital Complex
NCT07300462Enrolling by invitation· Phase 4
Oral cholera vaccine safety study for children

This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.

Hefei, Anhui
NCT07304284Recruiting· Phase 3
Cholera vaccine study for healthy adults and people with HIV

This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.

Durban, Eastern Cape
NCT07487077Recruiting· Phase 4
Extended interval oral cholera vaccine trial in Kenya

This trial tests giving the oral cholera vaccine on a longer dosing schedule than usual. It aims to see if a longer gap between doses still works well to protect people from cholera, especially helpful in places where returning for a second dose is hard.

Nairobi
NCT06455852Recruiting
How well does the cholera vaccine protect you?

This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.

Dhaka

Hear when a new Cholera Vaccination Reaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.